DYNAGLIPT LM 2.5/1000MG (Metformin (1000mg) + Linagliptin (2.5mg))

Dynaglipt LM 1000mg/2.5mg Tablet is a pharmaceutical formulation that combines two active ingredients to manage elevated blood glucose levels in individuals diagnosed with type 2 diabetes mellitus. This medication enhances the effectiveness of insulin and decreases the hepatic production of glucose, thereby contributing to better glycemic control. It may be utilized on its own or in conjunction with other antidiabetic agents as prescribed by a healthcare professional. Optimal results are achieved when this medication is integrated into a comprehensive treatment plan that includes a balanced diet and consistent physical activity. The specific dosage is tailored to the individual’s health status, current blood sugar readings, and any concurrent medications being administered. Taking the tablet with meals can help alleviate possible gastrointestinal discomfort. It is crucial to adhere to the prescribed dosing schedule and to refrain from altering the dosage or discontinuing use without consulting a healthcare provider. Continuing to follow dietary and exercise recommendations is essential for effective diabetes management. While this medication can be beneficial, it is important to remain alert for potential side effects, including headaches, nausea, dizziness, and skin rashes. Low blood sugar levels (hypoglycemia) can occur, particularly when used with other diabetes treatments such as insulin or sulfonylureas. Should any side effects persist or worsen, seek medical advice promptly.